The growing global burden of NCDs and the future of healthcare—how can we make an impact?

November 22nd-25th 2021

If you are having trouble reading this email, read the online version. Dear Bhinneka, Non-communicable diseases (NCDs) may not make headlines but they account for 71% of global deaths. Three-quarters of total NCD deaths are in developing markets, particularly China and India. What can healthcare leaders and policy-makers do to ensure that the focus comes back to these diseases? Register free Share with a peer Join experts in their field from Novartis, Indonesian Cancer Foundation, SingHealth Patient Advocacy Network, and MAKNA for a panel discussion on bringing NCDs back into the spotlight at Future of Healthcare Week Asia: Ruth Kuguru Region head, patient engagement & communications, innovative medicines Novartis Pharmaceuticals Aru Wisaksono Sudoyo Chairman Indonesian Cancer Foundation Ellil Mathiyan Lakshmanan Co-chair SingHealth Patient Advocacy Network, and President Ostomy Association of Singapore Farahida Mohd Farid General manager MAKNA (Majlis Kanser Nasional/National Cancer Council) Join us for answers to:  How do we bring a focus on NCDs back to the policy agenda? Which diseases are the most pressing concerns? Which types of cancer are particularly affected during the pandemic?  How can we play catch-up with the backlog of treatments? Register free   We look forward to you joining us and 3,000 of your peers next month. Yours sincerely, Laurel West Managing director, Economist Events, Asia  The Economist Group SPONSORS FURTHER READING Studying cancer genomes gene by gene could improve treatment Asian countries are at last abandoning zero-covid strategies asiaevents@economist.com Tel: +852 2585 3312 #EconFutureofHealthcare Join the conversation   Economist Events is now Economist Impact. View our global events. Should you wish to unsubscribe from receiving further emails relating to this event click here If you do not wish to receive further emails from Economist Impact please click here Economist Impact is part of the Economist Group. The Economist Group is a global organisation and operates a strict privacy policy around the world. To read more about us and our privacy policy please visit our website 1301 Cityplaza Four, 12 Taikoo Wan Road, Taikoo Shing, Hong Kong